http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107177014-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fced52a9fc48a318be09e2f29a2a531b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0069 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10 |
filingDate | 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95f88596d2813df67c600cfdf2cf5df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77c4e8c61c525cbe49affbf915fa072d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7cf9ca430331d3ebd7e9d8b7ef54fd |
publicationDate | 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107177014-A |
titleOfInvention | Protease hydrolytic intestinal mucosa technique |
abstract | Purification process is prepared the present invention relates to a kind of biological medicinal raw material, belongs to bioengineering field, specifically a kind of protease hydrolytic intestinal mucosa technique.The purpose of the present invention provides a kind of protease hydrolytic intestinal mucosa technique in order to improve the deficiencies in the prior art;The invention provides a kind of easy low molecular sodium heparin preparation, purification technique, obtained low molecular sodium heparin average molecular mass is in 4.5KDa or so, potency is not less than 180U/mg, higher than the 170U/mg of Chinese Pharmacopoeia requirement, and detects qualified according to Chinese Pharmacopoeia liquaemin examination criteria. |
priorityDate | 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.